Effects of Exenatide on Diabetes, Obesity, Cardiovascular Risk Factors, and Hepatic Biomarkers in Patients with Type 2 Diabetes

Obesity increases the risk of diabetes up to 90-fold and worsens hyperglycemia, hyperinsulinemia, insulin resistance, dyslipidemia, and nonalcoholic fatty liver disease. For patients with type 2 diabetes, weight loss can trigger improvements in all these conditions and decrease the need for glucose-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nielsen, Loretta L., Okerson, Ted, Holcombe, John, Hoogwerf, Byron
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Diabetes Technology Society 2008
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2771486/
https://ncbi.nlm.nih.gov/pubmed/19885351
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak